Insider · CIK 0001171527
HUTT PETER BARTON
Reports to the SEC for 17 companies · BERKELEY, CA
Transactions
50
Companies
17
Filings
6
CIK
0001171527
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2023-03-06 | CONCERT PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2023-03-06 | CONCERT PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2023-03-06 | CONCERT PHARMACEUTICALS, INC.U Disposition from Tender | — |
| 2023-03-06 | CONCERT PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2023-03-06 | CONCERT PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2023-03-06 | CONCERT PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2023-03-06 | CONCERT PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2023-03-06 | CONCERT PHARMACEUTICALS, INC.D Disposition to Issuer | — |
| 2023-03-06 | CONCERT PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2022-10-14 | CONCERT PHARMACEUTICALS, INC.S Sale | −$21.6K |
| 2022-10-14 | CONCERT PHARMACEUTICALS, INC.Stock Option (right to buy)M Exercise/Conversion | — |
| 2022-10-14 | CONCERT PHARMACEUTICALS, INC.M Exercise/Conversion | +$10.2K |
| 2022-06-09 | CONCERT PHARMACEUTICALS, INC.A Award | — |
| 2021-06-10 | CONCERT PHARMACEUTICALS, INC.Stock Option (right to buy)A Award | — |
| 2021-06-10 | CONCERT PHARMACEUTICALS, INC.A Award | — |
| 2020-10-23 | IMMUNOMEDICS INCD Disposition to Issuer | — |
| 2020-10-23 | IMMUNOMEDICS INCStock Option (Right to Buy)D Disposition to Issuer | — |
| 2020-10-23 | IMMUNOMEDICS INCRestricted Stock UnitD Disposition to Issuer | — |
| 2020-08-31 | CONCERT PHARMACEUTICALS, INC.M Exercise/Conversion | +$13.4K |
| 2020-08-31 | CONCERT PHARMACEUTICALS, INC.Stock Option (right to buy)M Exercise/Conversion | — |
| 2020-06-18 | IMMUNOMEDICS INCA Award | — |
| 2020-06-18 | IMMUNOMEDICS INCStock Option (right to buy)A Award | — |
| 2020-06-11 | CONCERT PHARMACEUTICALS, INC.Stock Option (right to buy)A Award | — |
| 2019-11-20 | MRNAModerna, Inc.S Sale | −$4.04M |
| 2019-11-20 | MRNAModerna, Inc. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2019-11-20 | MRNAModerna, Inc.M Exercise/Conversion | +$8,000 |
| 2019-09-17 | MRNAModerna, Inc. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2019-09-17 | MRNAModerna, Inc.S Sale | −$1.76M |
| 2019-09-17 | MRNAModerna, Inc.M Exercise/Conversion | +$4,000 |
| 2019-08-08 | CONCERT PHARMACEUTICALS, INC.M Exercise/Conversion | +$15.6K |
| 2019-08-08 | CONCERT PHARMACEUTICALS, INC.Non-qualified Stock Option (right to buy)M Exercise/Conversion | — |
| 2019-08-08 | CONCERT PHARMACEUTICALS, INC.S Sale | −$36.5K |
| 2019-06-27 | MRNAModerna, Inc. · Stock Option (Right to Buy)A Award | — |
| 2019-06-13 | CONCERT PHARMACEUTICALS, INC.Nonstatutory Stock Option (Right to Buy)A Award | — |
| 2019-06-07 | IMMUNOMEDICS INCA Award | — |
| 2019-06-07 | IMMUNOMEDICS INCStock Option (right to buy)A Award | — |
| 2018-07-25 | DCOYDecoy Therapeutics Inc. · Stock Option (right to buy)A Award | — |
| 2018-06-15 | RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2018-06-14 | CONCERT PHARMACEUTICALS, INC.Nonstatutory Stock Option (Right to Buy)A Award | — |
| 2018-04-02 | IMMUNOMEDICS INCStock Options (right to buy)A Award | — |
| 2018-04-02 | IMMUNOMEDICS INCA Award | — |
| 2017-07-26 | DCOYDecoy Therapeutics Inc. · Stock Option (right to buy)A Award | — |
| 2017-07-03 | IMMUNOMEDICS INCStock Options (right to buy)A Award | — |
| 2017-06-16 | RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2017-06-15 | CONCERT PHARMACEUTICALS, INC.Nonstatutory Stock Option (right to buy)A Award | — |
| 2017-02-10 | XOMA Royalty CorpNon-Qualified Share Option (right to buy)A Award | — |
| 2016-11-14 | CONCERT PHARMACEUTICALS, INC.M Exercise/Conversion | +$25K |
| 2016-11-14 | CONCERT PHARMACEUTICALS, INC.S Sale | −$217K |
| 2016-11-14 | CONCERT PHARMACEUTICALS, INC.Non-qualified Stock Option (right to buy)M Exercise/Conversion | — |
| 2016-08-29 | DNIB UNWIND, INC.Employee Stock Option (Right to Buy)M Exercise/Conversion | — |
Recent filings
- 4HUTT PETER BARTON0001209191-23-016165SEC(opens sec.gov)
- 4HUTT PETER BARTON0001209191-22-053967SEC(opens sec.gov)
- 4HUTT PETER BARTON0001209191-22-036288SEC(opens sec.gov)
- 4HUTT PETER BARTON0001209191-21-039746SEC(opens sec.gov)
- 4HUTT PETER BARTON0001104659-20-117801SEC(opens sec.gov)
- 4HUTT PETER BARTON0001209191-20-048893SEC(opens sec.gov)
Companies
- Cartesian Therapeutics, Inc.DirectorRNAC
- Celera CORPDirector
- CONCERT PHARMACEUTICALS, INC.Director
- CV THERAPEUTICS INCDirector
- Decoy Therapeutics Inc.DirectorDCOY
- DNIB UNWIND, INC.Director
- IMMUNOMEDICS INCDirector
- INTROGEN THERAPEUTICS INCDirector
- ISTA PHARMACEUTICALS INCDirector
- MMRGlobal, Inc.Director
- Moderna, Inc.DirectorMRNA
- MOMENTA PHARMACEUTICALS INCDirector
- Phase Forward IncDirector
- Q Therapeutics, Inc.Director
- QUICK-MED TECHNOLOGIES INCDirector, Resigned effective 11/5/2003
- Seres Therapeutics, Inc.DirectorMCRB
- XOMA Royalty CorpDirector
Address
C/O XOMA LTD. 2910 SEVENTH STREET
BERKELEY, CA, 94710